A 2026 systematic review in eClinicalMedicine corroborated this trajectory, finding consistent and clinically meaningful rebound across body weight, waist circumference, glycemic control, and blood pressure after discontinuation
You're supposed to grow revenue while cutting costs, hire staff when nobody's applying, and somehow keep providers from burning out
Naltrexone has a half-life of 5 hours, and extended-release bupropion has a half-life of 21 hours, whereas weekly dosed GLP-1 receptor agonist medications have a half-life of 7 days, Rhodes said
Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al
Licensed clinicians in Omzo's network make individual prescribing determinations based on each patient's full medical history, including any prior GLP-1 experience, current medications, and existing health conditions
Retatrutide has not yet received MHRA marketing authorisation and is not approved for NHS use